BVF as of June 30, 2018
Portfolio Holdings for BVF
BVF holds 51 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chemocentryx | 9.0 | $93M | 7.0M | 13.17 | |
| Merus N V (MRUS) | 8.7 | $89M | 3.9M | 22.76 | |
| Array BioPharma | 7.7 | $78M | 4.7M | 16.78 | |
| Cytokinetics (CYTK) | 4.5 | $46M | 5.6M | 8.30 | |
| ArQule | 4.0 | $41M | 7.4M | 5.53 | |
| Blueprint Medicines (BPMC) | 4.0 | $41M | 647k | 63.48 | |
| Kura Oncology (KURA) | 3.6 | $37M | 2.1M | 18.20 | |
| Mirati Therapeutics | 3.6 | $37M | 745k | 49.30 | |
| Cti Biopharma | 3.4 | $35M | 6.9M | 4.98 | |
| Xencor (XNCR) | 3.1 | $32M | 870k | 37.01 | |
| Xoma Corp Del (XOMA) | 3.1 | $31M | 1.5M | 20.88 | |
| Concert Pharmaceuticals I equity | 3.0 | $31M | 1.8M | 16.83 | |
| Infinity Pharmaceuticals (INFIQ) | 2.8 | $29M | 15M | 1.91 | |
| Pieris Pharmaceuticals | 2.6 | $27M | 5.3M | 5.07 | |
| Ionis Pharmaceuticals (IONS) | 2.3 | $24M | 570k | 41.67 | |
| Anaptysbio Inc Common (ANAB) | 2.3 | $24M | 335k | 71.04 | |
| Biolinerx Ltd-spons | 2.3 | $23M | 26M | 0.90 | |
| Forward Pharma A/s | 2.3 | $23M | 8.5M | 2.72 | |
| Galmed Pharmaceuticals | 2.0 | $21M | 1.8M | 11.90 | |
| Corvus Pharmaceuticals (CRVS) | 2.0 | $21M | 1.9M | 10.98 | |
| Immune Design | 1.9 | $19M | 4.2M | 4.55 | |
| Five Prime Therapeutics | 1.7 | $18M | 1.1M | 15.81 | |
| Verastem | 1.5 | $15M | 2.2M | 6.88 | |
| Spero Therapeutics (SPRO) | 1.5 | $15M | 1.0M | 14.67 | |
| Mei Pharma | 1.2 | $12M | 3.1M | 3.94 | |
| Arcus Biosciences Incorporated (RCUS) | 1.1 | $12M | 960k | 12.24 | |
| Ironwood Pharmaceuticals (IRWD) | 1.1 | $12M | 607k | 19.12 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.0 | $10M | 1.9M | 5.20 | |
| Protagonist Therapeutics (PTGX) | 0.9 | $9.5M | 1.4M | 6.72 | |
| Oncomed Pharmaceuticals | 0.9 | $9.5M | 4.1M | 2.31 | |
| Spring Bk Pharmaceuticals In | 0.9 | $9.3M | 786k | 11.85 | |
| Regulus Therapeutics | 0.9 | $9.0M | 14M | 0.66 | |
| Syndax Pharmaceuticals (SNDX) | 0.8 | $8.7M | 1.2M | 7.02 | |
| Vbi Vaccines | 0.8 | $8.5M | 3.1M | 2.75 | |
| Albireo Pharma | 0.8 | $7.8M | 220k | 35.50 | |
| Contrafect | 0.7 | $7.4M | 3.4M | 2.21 | |
| Erytech Pharma Sa | 0.7 | $7.2M | 625k | 11.54 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $6.6M | 721k | 9.20 | |
| Gtx Inc Del | 0.6 | $5.9M | 386k | 15.31 | |
| Merrimack Pharma | 0.5 | $5.5M | 1.1M | 4.91 | |
| Surface Oncology | 0.5 | $5.5M | 334k | 16.31 | |
| Alpine Immune Sciences | 0.5 | $4.9M | 643k | 7.57 | |
| Genocea Biosciences | 0.4 | $4.5M | 5.3M | 0.86 | |
| Tocagen | 0.4 | $4.4M | 471k | 9.34 | |
| Sunesis Pharmaceuticals Inc Ne | 0.3 | $3.6M | 1.7M | 2.12 | |
| Molecular Templates | 0.3 | $3.6M | 689k | 5.23 | |
| Aduro Biotech | 0.2 | $2.1M | 296k | 7.00 | |
| Essa Pharma (EPIX) | 0.2 | $2.1M | 553k | 3.78 | |
| Vical | 0.1 | $1.5M | 1.3M | 1.15 | |
| Loxo Oncology | 0.1 | $709k | 4.1k | 173.39 | |
| Zymeworks | 0.0 | $293k | 20k | 14.79 |
